Vous êtes sur la page 1sur 3

Student _______________________________________________________

Date __________________________

Instructor _____________________________________________________

Date __________________________

PERFORMANCE CHECKLIST SKILL 21-6 USING METERED-DOSE INHALERS

NP

Comments

1. Checked accuracy and completeness of each


MAR against medication order, clarified incomplete or unclear orders with health care provider.

____

____

____

___________________________

2. Reviewed pertinent information related to


medication.

____

____

____

___________________________

3. Assessed patients medical history, history of


allergies, and medication history.

____

____

____

___________________________

4. Assessed respiratory pattern, auscultated breath


sounds.

____

____

____

___________________________

5. Assessed patients ability to hold, manipulate,


and depress canister and inhaler.

____

____

____

___________________________

6. Assessed patients readiness and ability to learn.

____

____

____

___________________________

7. Assessed patients knowledge and understanding of disease and purpose and action of medications.

____

____

____

___________________________

1. Identified expected outcomes.

____

____

____

___________________________

2. Explained procedure to patient, explained specifics if patient wished to self-administer drug.

____

____

____

___________________________

1. Prepared medications for inhalation, checked


label of medication against MAR twice, checked
expiration date.

____

____

____

___________________________

2. Took medication(s) to patient at correct time,


applied the six rights of medication administration.

____

____

____

___________________________

3. Identified patient using two identifiers.

____

____

____

___________________________

4. Compared MAR with medication labels at


patients bedside, asked patient if he or she had
allergies.

____

____

____

___________________________

5. Discussed purpose of each medication, action,


and possible adverse effects; allowed patient to
ask any questions; explained what a metereddose is and how to administer it, warned about
overuse and side effects.

____

____

____

___________________________

ASSESSMENT

PLANNING

IMPLEMENTATION

Copyright 2014 by Mosby, an imprint of Elsevier Inc. All rights reserved.

Copyright 2014, 2010 by Mosby, an imprint of Elsevier Inc.

271

NP

Comments

____

____

____

___________________________

a. Removed mouthpiece cover from inhaler


after inserting MDI canister into holder.

____

____

____

___________________________

b. Shook inhaler well for 2 to 5 seconds.

____

____

____

___________________________

c. Held inhaler in dominant hand.

____

____

____

___________________________

d. Instructed patient to position inhaler properly.

____

____

____

___________________________

e. Had patient take deep breath and exhale


completely.

____

____

____

___________________________

f. Had patient hold inhaler in three-point or


bilateral hand position when positioned
properly.

____

____

____

___________________________

g. Instructed patient to tilt head back and inhale


slowly and deeply through mouth for 3 to 5
seconds while depressing canister fully.

____

____

____

___________________________

h. Had patient hold breath for about 10


seconds.

____

____

____

___________________________

i. Removed MDI from mouth before exhaling.

____

____

____

___________________________

a. Removed mouthpiece cover from MDI and


mouthpiece of spacer device.

____

____

____

___________________________

b. Shook inhaler well for 2 to 5 seconds.

____

____

____

___________________________

c. Inserted MDI into end of spacer device.

____

____

____

___________________________

d. Instructed patient to place spacer mouthpiece


in mouth and close lips, avoided covering
exhalation slots with lips.

____

____

____

___________________________

e. Had patient breathe normally through


mouthpiece.

____

____

____

___________________________

f. Instructed patient to spray one puff into


spacer device.

____

____

____

___________________________

g. Had patient breathe in slowly and fully.

____

____

____

___________________________

h. Instructed patient to hold breath for 10


seconds.

____

____

____

___________________________

9. Instructed patient to wait appropriate length


between inhalations.

____

____

____

___________________________

6. Allowed adequate time for patient to manipulate equipment, explained and demonstrated
how canister fits into inhaler.
7. Explained steps for administering MDI without
spacer:

8. Explained steps to administer MDI using a


spacer.

272

Copyright 2014 by Mosby, an imprint of Elsevier Inc. All rights reserved.

Copyright 2014, 2010 by Mosby, an imprint of Elsevier Inc.

NP

Comments

10. Instructed patient to not repeat inhalation


before next scheduled.

____

____

____

___________________________

11. Warned patient they may feel gagging sensation.

____

____

____

___________________________

12. Instructed patient to rinse and spit with warm


water 2 minutes after dose.

____

____

____

___________________________

13. Instructed patient in daily cleaning of inhaler.

____

____

____

___________________________

14. Asked if patient had any questions.

____

____

____

___________________________

15. Assisted patient to comfortable position, performed hand hygiene.

____

____

____

___________________________

1. Had patient explain and demonstrate steps in


use and cleaning of inhaler.

____

____

____

___________________________

2. Asked patient to explain drug schedule and


dose or medication.

____

____

____

___________________________

3. Asked patient to describe side effects of medication and criteria for calling health care provider.

____

____

____

___________________________

4. Assessed patients respirations, breath sounds,


and peak flow measures after medication
administration if ordered.

____

____

____

___________________________

5. Identified unexpected outcomes.

____

____

____

___________________________

1. Recorded drug, dose, route, number of inhalations, and time on MAR; included initials or
signature; recorded patient teaching and validation of understanding in nurses notes.

____

____

____

_________________________

2. Recorded patients response to MDI, side effects,


and patients ability to use MDI.

____

____

____

_________________________

3. Reported adverse effects/patient response/


withheld drugs to nurse in charge or health care
provider.

____

____

____

_________________________

EVALUATION

RECORDING AND REPORTING

Copyright 2014 by Mosby, an imprint of Elsevier Inc. All rights reserved.

Copyright 2014, 2010 by Mosby, an imprint of Elsevier Inc.

273

Vous aimerez peut-être aussi